Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape

Biosensors and Bioelectronics(2020)10.1016/j.bios.2020.112454Source: DataRank Database

Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape is a research paper published in Biosensors and Bioelectronics (2020). On theSindex it has a DataRank of 0. It has been cited 394 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access394 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 8.44)OA: greenTopics (45)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Dana L. Cortade ORCID,Elaine Ng ORCID,Shan X. Wang ORCID,Neeraja Ravi ORCID

Live enrichment

PubMed:32729549 PMC:PMC7368663 OpenAlex:https://openalex.org/W3042554514

NCI NIH HHS

Grant: U54 CA199075

National Institutes of Health

Grant: R01 AI125197

Stanford

Cancer-Translational Nanotechnology Training

FWCI

8.44

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7368663

publisherhttps://api.elsevier.com/content/article/PII:S0956566320304486?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0956566320304486?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bios.2020.112454

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingBiosensors and Analytical Detection

MeSH Terms

Point-of-Care TestingBetacoronavirusCOVID-19SARS-CoV-2HumansImmunoglobulin GImmunoglobulin MImmunoassayPneumonia, ViralRNA, ViralSpecimen HandlingUnited StatesUnited States Food and Drug AdministrationBiosensing TechniquesCoronavirus InfectionsReverse Transcriptase Polymerase Chain ReactionPandemics

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Point-of-care testingMedicineDiagnostic testVirologyOutbreakMolecular diagnosticsSerology2019-20 coronavirus outbreakDiseaseImmunologyAntibodyBiologyInfectious disease (medical specialty)PathologyVeterinary medicineBioinformaticsImmunoassayRT-PCRPoint-of-careDiagnostic TestingCovid-19Sars-cov-2Fda-eua

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)

10.6084/m9.figshare.14569955.v1figshare

Additional file 1 of A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)

10.6084/m9.figshare.14569955figshare

Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)